Leukemia Research
Volume 33, Issue 11 , Pages 1481-1484 , November 2009

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

  • Arturo Vega-Ruiz

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Jorge E. Cortes

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Matjaz Sever

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Taghi Manshouri

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Alfonso Quintás-Cardama

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Raja Luthra

      Affiliations

    • Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Hagop M. Kantarjian

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Srdan Verstovsek

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • Corresponding Author InformationCorresponding author at: UT MD Anderson Cancer Center, Department of Leukemia, Unit 428, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Tel.: +1 713 745 3429; fax: +1 713 794 4297.

Received 25 November 2008 ,Revised 18 December 2008 ,Accepted 23 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(08)00567-5

doi: 10.1016/j.leukres.2008.12.020

Leukemia Research
Volume 33, Issue 11 , Pages 1481-1484 , November 2009

Article Tools

* Image Usage & Resolution